Screener
Ocular Therapeutix OCUL Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
FAQ
- What is Ocular Therapeutix's free cash flow?
- Ocular Therapeutix (OCUL) reported free cash flow of -$70.66M in Q1 2026.
- How has Ocular Therapeutix's free cash flow changed year-over-year?
- Ocular Therapeutix's free cash flow decreased by 51.6% year-over-year, from -$46.6M to -$70.66M.
- What is the long-term trend for Ocular Therapeutix's free cash flow?
- Over 4 years (2021 to 2025), Ocular Therapeutix's free cash flow has grown at a 34.3% compound annual growth rate (CAGR), from -$66.74M to -$216.89M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Ocular Therapeutix's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude